<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJBD</journal-id><journal-title-group><journal-title>Open Journal of Blood Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-3180</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojbd.2023.132009</article-id><article-id pub-id-type="publisher-id">OJBD-125452</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Some Haematological Parameters in Primary Hypertensive Subjects Attending a Tertiary Hospital in Nigeria
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eledo</surname><given-names>Benjamin Onyema</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akanno</surname><given-names>Kelechi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ajugwo</surname><given-names>Anslem</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Onuoha</surname><given-names>Emmanuel Chinedu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Medical Laboratory Science, Madonna University, Elele, Nigeria</addr-line></aff><aff id="aff2"><addr-line>Department of Medical Laboratory Science, Federal University, Otuoke, Nigeria</addr-line></aff><pub-date pub-type="epub"><day>17</day><month>05</month><year>2023</year></pub-date><volume>13</volume><issue>02</issue><fpage>69</fpage><lpage>77</lpage><history><date date-type="received"><day>24,</day>	<month>February</month>	<year>2023</year></date><date date-type="rev-recd"><day>3,</day>	<month>June</month>	<year>2023</year>	</date><date date-type="accepted"><day>6,</day>	<month>June</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: 
  Hypertension is a persistent elevation of blood pressure in the arteries which if not properly managed can lead to stroke, heart failure, atrial fibrillation, peripheral vascular disease and other life threatening outcomes. This study investigated some haematological parameters of Primary hypertensive subjects.
   
  <b>Objectives: </b>
  To compare some haematological parameters (haematocrit, haemoglobin concentration, Platelets count, White Blood Cells count, red blood cell count and Red Cells Indices between hypertensive and normotensive subjects
  . 
  <b>Materials and methods: </b>
  Blood samples were collected from 76 known hypertensive subjects between 30 
  -
   70 years attending the Cardiology clinic of the University of Abuja Teaching Hospital Gwagwalada. Another 37 normotensive subjects between 30 
  -
   65 years served as the control. All subjects gave their consents. Platelets count, Haemoglobin estimation, Packed Cell Volume, Red Blood Cell Count, Mean Cell Volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration and White Blood Cell count were determined using Mythic 22 five parts haematology analyzer.
   
  <b>Results: </b>
  Results for Hypertensive and Control subjects were, White Blood Cell, 5.76 &#177; 1.45 &#215; 10<sup>9</sup>/l and 4.76 &#177; 1.03 &#215; 10<sup>9</sup>/l, Platelet count, 248.7552.45 &#215; 10<sup>9</sup>/l and 284.95 &#177; 27.66 &#215; 10<sup>9</sup>/l, Mean Cell Volume, 91.81 &#177; 3.05
   
  fl and 85.68 &#177; 6.48
   
  fl, Mean Cell Haemoglobin, 30.59 &#177; 1.04
   
  pg and 27.922 &#177; 2.74
   
  pg, Mean Cell Haemoglobin Concentration, 33.34 &#177; 0.61
   
  g/dl and 32.32 &#177; 0.93
   
  g/dl, Red Blood Cell, 4.33 &#177; 0.39 &#215; 10<sup>9</sup>/l and 4.50 &#177; 0.52 &#215; 10<sup>9</sup>/l, Packed Cell Volume, 39
  %
   &#177; 3.15% and 40
  %
   &#177; 4.41% and Haemoglobin, 13.21 &#177; 1.10
   
  g/dl and 13.50 &#177; 1.63
   
  g/dl respectively. Mean Cell Volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration (Red cells indices) were significantly higher in hypertensive compared to normotensive subjects
   
  (P 
  &lt;
   
  0.05), total White Blood Cell count was also higher in hypertensive than normotensive but not statistically significant (P &gt; 0.05). However, Platelet counts, Red Blood Cell, Packed Cell Volume and Haemoglobin were significantly lower in hypertensive compared to normotensive (P 
  &lt;
   
  0.05). All the parameters were within established reference ranges for the age and sex of the subjects. Our findings show that hypertension may lead to haematological derangement, if not properly managed. Conclusively, haematological parameters can be used to monitor the prognosis of the disease and manage hypertensive related complications. It is important to assess haematological parameters for hypertensive individuals which may help to prevent complications associated with haematological disorders.
 
</p></abstract><kwd-group><kwd>Hypertension</kwd><kwd> Haematological Parameters</kwd><kwd> Tertiary Hospital</kwd><kwd> Nigeria</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>As of 2014, approximately one billion adults or 22% of the population of the world have hypertension. It is slightly more frequent in men, in those of low socioeconomic status, and it becomes more common with age. It is common in high, medium, and low income countries [<xref ref-type="bibr" rid="scirp.125452-ref1">1</xref>] . In 2004, rates of high blood pressure were highest in Africa, (30% for both sexes) and lowest in the Americas (18% for both sexes). Rates also vary markedly within regions with rates as low as 3.4% (men) and 6.8% (women) in rural India and as high as 68.9% (men) and 72.5% (women) in Poland [<xref ref-type="bibr" rid="scirp.125452-ref2">2</xref>] Rates in Africa were about 45% in 2016 [<xref ref-type="bibr" rid="scirp.125452-ref3">3</xref>] .</p><p>Hypertension is a major global health problem and public health challenge, demanding a vast proportion of health care resources directly and indirectly because of its high and increasing prevalence and the concomitant risks of cardiovascular and kidney disease, disability, adjusted life years and mortality [<xref ref-type="bibr" rid="scirp.125452-ref2">2</xref>] . Various risk factors have been implicated in the development of hypertension, some of which include genetic, environmental, psychosocial and inflammatory factors [<xref ref-type="bibr" rid="scirp.125452-ref4">4</xref>] .</p><p>It has been hypothesized that increased adherence of the stimulated leukocytes to the vascular endothelium, causes capillary leukocytosis and subsequent increased vascular resistance; a raised WBC count may therefore indicate increased catecholamine levels or enhanced sympathetic nervous system activity, thus causing an increase in blood pressure and eventually resulting in sustained hypertension [<xref ref-type="bibr" rid="scirp.125452-ref5">5</xref>] . Recent reports suggest that people with hypertension have lower MCVs than subjects with normal blood pressure [<xref ref-type="bibr" rid="scirp.125452-ref6">6</xref>] . Haematocrit is a determinant of whole blood viscosity. Viscosity affects peripheral resistance to blood flow, and peripheral resistance affects blood pressure [<xref ref-type="bibr" rid="scirp.125452-ref7">7</xref>] . Most hypertensive patients exhibit increased blood viscosity compared with healthy controls [<xref ref-type="bibr" rid="scirp.125452-ref8">8</xref>] . There are indications that systolic blood pressure (SBP) and diastolic blood pressure (DBP) may increase with increasing haemoglobin (Hb) levels [<xref ref-type="bibr" rid="scirp.125452-ref9">9</xref>] . In previous research among haemodialysis patients, the administration of erythropoietin, an erythropoiesis-stimulating protein used for the treatment of anaemia, was related to an elevated blood pressure [<xref ref-type="bibr" rid="scirp.125452-ref10">10</xref>] . Formation of platelet plug (primary haemostasis) is associated with activation of the coagulation cascade with resultant fibrin deposition and linking. Normal platelets can respond to an abnormality on the vessel wall rather than to haemorrhage, resulting in inappropriate platelet adhesion/activation and thrombosis; the formation of a clot within an intact vessel which can lead to hypertension (secondary haemostasis) [<xref ref-type="bibr" rid="scirp.125452-ref11">11</xref>] .</p><p>The study is therefore aimed to evaluate some haematological parameters in primary hypertensive subjects attending a tertiary hospital in Nigeria.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Study Population</title><p>This research population were drawn from a group of subjects with primary hypertensive cases who have been on medications for 6 - 12 months period in University of Abuja Teaching Hospital, Nigeria’s Federal Capital Territory. The subjects were between 18 - 65 years of age.</p></sec><sec id="s2_2"><title>2.2. Sample Size</title><p>A cross section of one hundred and thirteen (113) patients was assessed randomly for the presence of Hypertension.</p><p>The presence of Hypertension was evaluated using stethoscope and sphygmomanometer cuff.</p><p>Sample size was determined using the Leslie Kish formula (Kish, 1965).</p><p>n = Z 2 p q / d 2</p><p>where = n = sample size minimum</p><p>Z = 95% confidence interval = 1.96</p><p>p = proportion of the target population (8%) = 0.08</p><p>q = 1.0 − p = 0.92</p><p>d = degree of accuracy (95% interval) = 0.05%</p><p>n = 1.96 2 &#215; 0.08 &#215; 0.92 / 0.05 2 = 3.8416 &#215; 0.08 &#215; 0.92 / 0.0025 = 0.28274176 / 0.0025 n = 113</p></sec><sec id="s2_3"><title>2.3. Inclusion Criteria for Subjects</title><p>Samples were collected from Individuals with Hypertension attending Cardiology Clinic at the University of Abuja Teaching Hospital (UATH) Gwagwalada Abuja that willingly gave their consent.</p><p>The presence of the history of primary hypertension and elevated blood pressure is of ≥140/90 mmHg.</p><p>Not having any underlying causes and having no history of administration of anticoagulant therapy.</p><p>No history of chronic viral infection or liver diseases (HBV, HCV and HIV).</p></sec><sec id="s2_4"><title>2.4. Exclusion Criteria for Subjects</title><p>Normotensive individuals who refused consent and also those without any Family history of Hypertension. Known cases of clotting and bleeding disorders, pregnant subjects and those suffering from hepatitis B and C, Tuberculosis, diabetes and HIV were excluded from the study.</p></sec><sec id="s2_5"><title>2.5. Ethical Clearance</title><p>Ethical approval was obtained from University of Abuja Teaching Hospital (UATH) Ethical committee with approval number of UATH/HREC/PR/2019/023.</p></sec><sec id="s2_6"><title>2.6. Research Protocol</title><p>Using aseptic precaution, 5 mls of blood were collected from each subject and dispensed into K<sub>3</sub>EDTA bottle for complete blood count. The samples were analyzed within six hours using MYTHIC22 five parts haematology analyzer (by PZ CORMAY).</p></sec><sec id="s2_7"><title>2.7. Statistical Analysis</title><p>The data obtained were analyzed using SPSS software version 16. Comparisons of different means were done using independent students T-test and one-way analysis of variance (ANOVA).</p></sec></sec><sec id="s3"><title>3. Results</title><p><xref ref-type="table" rid="table1">Table 1</xref> was the comparison of some haematological parameters between hypertensive and normotensive subjects. Mean Cell Volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration (Red cells indices) were significantly higher in hypertensive compared to normotensive (P &lt; 0.05). Total White Blood Cell count was also higher in hypertensive than normotensive but not statistically significant (P &gt; 0.05). However, Platelet counts, Red Blood Cell, Packed Cell Volume and Haemoglobin concentrationwere significantly lower in hypertensive subjects when compared with normotensive subjects (P &lt; 0.05).</p><p><xref ref-type="table" rid="table2">Table 2</xref> was the Comparison of some haematological parameters in hypertensive and normotensive subjects in different gender. The platelets count, total white cell count, mean cell volume, mean cell haemoglobin concentration were significantly lower among male hypertensive subjects when compared with the females, while the mean cell haemoglobin, red blood cell count, packed cell volume and haemoglobin concentration were significantly higher (P &lt; 0.001).</p><p><xref ref-type="table" rid="table3">Table 3</xref> was the comparison of some haematological parameters in hypertensive subjects in different age groups. When the haematological parameters were compared among the different age groups, they showed no significant difference (P &gt; 0.05).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison of some haematological parameters between hypertensive and normotensive subjects</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameter</th><th align="center" valign="middle" >Control</th><th align="center" valign="middle" >Hypertensive</th><th align="center" valign="middle" >T</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >PLT</td><td align="center" valign="middle" >284.95 &#177; 27.66</td><td align="center" valign="middle" >248.75 &#177; 52.45</td><td align="center" valign="middle" >4.79</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >WBC</td><td align="center" valign="middle" >4.76 &#177; 1.04</td><td align="center" valign="middle" >5.76 &#177; 1.45</td><td align="center" valign="middle" >4.18</td><td align="center" valign="middle" >0.399</td></tr><tr><td align="center" valign="middle" >MCV</td><td align="center" valign="middle" >85.68 &#177; 6.48</td><td align="center" valign="middle" >91.81 &#177; 3.04</td><td align="center" valign="middle" >5.46</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >MCH</td><td align="center" valign="middle" >27.92 &#177; 2.74</td><td align="center" valign="middle" >30.59 &#177; 1.04</td><td align="center" valign="middle" >5.76</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >MCHC</td><td align="center" valign="middle" >32.32 &#177; 0.93</td><td align="center" valign="middle" >33.34 &#177; 0.61</td><td align="center" valign="middle" >6.11</td><td align="center" valign="middle" >0.009</td></tr><tr><td align="center" valign="middle" >RBC</td><td align="center" valign="middle" >4.51 &#177; 0.53</td><td align="center" valign="middle" >4.33 &#177; 0.0.39</td><td align="center" valign="middle" >1.83</td><td align="center" valign="middle" >0.040</td></tr><tr><td align="center" valign="middle" >PCV</td><td align="center" valign="middle" >40.58 &#177; 4.41</td><td align="center" valign="middle" >39.63 &#177; 3.16</td><td align="center" valign="middle" >1.17</td><td align="center" valign="middle" >0.041</td></tr><tr><td align="center" valign="middle" >HB</td><td align="center" valign="middle" >13.50 &#177; 1.63</td><td align="center" valign="middle" >13.21 &#177; 1.10</td><td align="center" valign="middle" >0.97</td><td align="center" valign="middle" >0.007</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of some haematological parameters between hypertensive and normotensive subjects in different gender</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameter</th><th align="center" valign="middle" >Male Control</th><th align="center" valign="middle" >Female Control</th><th align="center" valign="middle" >Male Hypertensive</th><th align="center" valign="middle" >Female Hypertensive</th><th align="center" valign="middle" >F</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >PLT</td><td align="center" valign="middle" >285.03 &#177; 24.53</td><td align="center" valign="middle" >283.50 &#177; 84.15</td><td align="center" valign="middle" >235.52 &#177; 59.17</td><td align="center" valign="middle" >253.32 &#177; 50.4</td><td align="center" valign="middle" >6.13</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >WBC</td><td align="center" valign="middle" >4.71 &#177; 1.04</td><td align="center" valign="middle" >5.65 &#177; 0.49</td><td align="center" valign="middle" >5.66 &#177; 1.45</td><td align="center" valign="middle" >5.82 &#177; 1.51</td><td align="center" valign="middle" >4.91</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >MCV</td><td align="center" valign="middle" >85.57 &#177; 6.65</td><td align="center" valign="middle" >87.45 &#177; 1.06</td><td align="center" valign="middle" >91.56 &#177; 3.42</td><td align="center" valign="middle" >91.92 &#177; 2.94</td><td align="center" valign="middle" >15.42</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >MCH</td><td align="center" valign="middle" >27.82 &#177; 2.79</td><td align="center" valign="middle" >29.55 &#177; 0.92</td><td align="center" valign="middle" >30.48 &#177; 0.96</td><td align="center" valign="middle" >29.71 &#177; 2.1</td><td align="center" valign="middle" >19.22</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >MCHC</td><td align="center" valign="middle" >32.31 &#177; −0.95</td><td align="center" valign="middle" >32.40 &#177; 0.42</td><td align="center" valign="middle" >33.28 &#177; 0.67</td><td align="center" valign="middle" >33.36 &#177; 0.59</td><td align="center" valign="middle" >15.86</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >RBC</td><td align="center" valign="middle" >4.49 &#177; 0.522</td><td align="center" valign="middle" >4.80 &#177; 0.57</td><td align="center" valign="middle" >4.64 &#177; 0.30</td><td align="center" valign="middle" >4.16 &#177; 0.32</td><td align="center" valign="middle" >10.57</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >PCV</td><td align="center" valign="middle" >40.50 &#177; 4.47</td><td align="center" valign="middle" >42.00 &#177; 4.24</td><td align="center" valign="middle" >42.44 &#177; 2.02</td><td align="center" valign="middle" >38.16 &#177; 2.56</td><td align="center" valign="middle" >10.95</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >HB</td><td align="center" valign="middle" >13.47 &#177; 1.65</td><td align="center" valign="middle" >14.10 &#177; 1.41</td><td align="center" valign="middle" >14.13 &#177; 0.75</td><td align="center" valign="middle" >12.73 &#177; 0.92</td><td align="center" valign="middle" >8.67</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of some haematological parameters in hypertensive subjects in different age groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameter</th><th align="center" valign="middle" >31 - 40 years</th><th align="center" valign="middle" >41 - 50 years</th><th align="center" valign="middle" >51 - 60 years</th><th align="center" valign="middle" >61 years above</th><th align="center" valign="middle" >F</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >PLT</td><td align="center" valign="middle" >256.79 &#177; 54.27</td><td align="center" valign="middle" >245.56 &#177; 66.63</td><td align="center" valign="middle" >241.14 &#177; 51.54</td><td align="center" valign="middle" >253.58 &#177; 32.98</td><td align="center" valign="middle" >0.38</td><td align="center" valign="middle" >0.77</td></tr><tr><td align="center" valign="middle" >WBC</td><td align="center" valign="middle" >5.96 &#177; 1.24</td><td align="center" valign="middle" >5.96 &#177; 1.91</td><td align="center" valign="middle" >5.48 &#177; 1.00</td><td align="center" valign="middle" >5.36 &#177; 1.61</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >0.46</td></tr><tr><td align="center" valign="middle" >MCV</td><td align="center" valign="middle" >92.65 &#177; 2.87</td><td align="center" valign="middle" >91.50 &#177; 2.75</td><td align="center" valign="middle" >91.75 &#177; 3.04</td><td align="center" valign="middle" >92.40 &#177; 2.82</td><td align="center" valign="middle" >0.66</td><td align="center" valign="middle" >0.58</td></tr><tr><td align="center" valign="middle" >MCH</td><td align="center" valign="middle" >31.04 &#177; 0.92</td><td align="center" valign="middle" >30.53 &#177; 0.89</td><td align="center" valign="middle" >30.45 &#177; 1.11</td><td align="center" valign="middle" >30.72 &#177; 0.94</td><td align="center" valign="middle" >1.39</td><td align="center" valign="middle" >0.25</td></tr><tr><td align="center" valign="middle" >MCHC</td><td align="center" valign="middle" >33.53 &#177; 0.55</td><td align="center" valign="middle" >33.36 &#177; 0.61</td><td align="center" valign="middle" >33.24 &#177; 0.63</td><td align="center" valign="middle" >33.24 &#177; 0.65</td><td align="center" valign="middle" >1.00</td><td align="center" valign="middle" >0.39</td></tr><tr><td align="center" valign="middle" >RBC</td><td align="center" valign="middle" >4.27 &#177; 0.33</td><td align="center" valign="middle" >4.29 &#177; 0.35</td><td align="center" valign="middle" >4.38 &#177; 0.37</td><td align="center" valign="middle" >4.23 &#177; 0.45</td><td align="center" valign="middle" >0.38</td><td align="center" valign="middle" >0.77</td></tr><tr><td align="center" valign="middle" >PCV</td><td align="center" valign="middle" >39.53 &#177; 2.74</td><td align="center" valign="middle" >39.19 &#177; 2.81</td><td align="center" valign="middle" >40.04 &#177; 3.14</td><td align="center" valign="middle" >39.37 &#177; 3.97</td><td align="center" valign="middle" >0.26</td><td align="center" valign="middle" >0.85</td></tr><tr><td align="center" valign="middle" >HB</td><td align="center" valign="middle" >13.4 &#177; 0.91</td><td align="center" valign="middle" >13.08 &#177; 1.06</td><td align="center" valign="middle" >13.31 &#177; 1.10</td><td align="center" valign="middle" >13.09 &#177; 1.36</td><td align="center" valign="middle" >0.20</td><td align="center" valign="middle" >0.089</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>Platelets and WBCs are essential parameters used in assessing thrombosis. The haematological indices reflect oxidative stress and inflammatory state that postulate as major mechanisms of hypertension and its vascular complication. In this study, the Mean Cell Volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration (Red cells indices) were significantly higher in hypertensive compared to normotensive, total white blood cell count was also higher in hypertensive than normotensive but not statistically significant. However, Platelet counts, Red Blood Cell, Packed Cell Volume and Haemoglobin were significantly lower in hypertensive compared to normotensive. The same pattern was observed in comparison of haematological parameters in hypertensive and normotensive subjects in different gender however, there was no significant difference among different age groups.</p><p>The elevated total White Blood Cell count in hypertensive patient may be as a result of abnormal function of vascular system in those patients that may cause activation of cytokine system to renew the endothelial injury; involve in differentiation and proliferation of hematopoietic cell [<xref ref-type="bibr" rid="scirp.125452-ref12">12</xref>] . An increase in blood pressure occurs when activated and differentiated total white blood cell counts release additional cytokines thereby raising attachment of the stimulated leukocytes to the vascular endothelium; resulting to capillary leukocytosis and subsequent elevated vascular resistance [<xref ref-type="bibr" rid="scirp.125452-ref13">13</xref>] .</p><p>In this study the mean value for haemoglobin concentrations, Red Blood Cell and Packed Cell Volume were shown to be lower among hypertensive compared to normotensive subjects (P &gt; 0.05). This could be attributed to the release of haemolysis, haemoglobin and arginase enzyme to circulation from erythrocytes. This free haemoglobin is a remover of nitric oxide that is produced in the endothelial cell that lines the blood vessels, which is important for relaxation of blood vessels while arginase enzyme reduces the substrate used for nitric oxide synthesis by conversion of arginine to ornithine, thereby reducing nitric oxide production [<xref ref-type="bibr" rid="scirp.125452-ref14">14</xref>] .</p><p>This is in agreement with previous studies where hypertension is a complication of haemolysis and associated with haemolytic anaemia [<xref ref-type="bibr" rid="scirp.125452-ref15">15</xref>] .</p><p>Our finding is also consistent with a previous report which indicated that haematological disorder was reported which may be a powerful signal of hypertensive end-organ damage, particularly kidney failure [<xref ref-type="bibr" rid="scirp.125452-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.125452-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.125452-ref18">18</xref>] . Precisely, low Haemoglobin levels causes anaemia and heart failure [<xref ref-type="bibr" rid="scirp.125452-ref19">19</xref>] .</p><p>In this study, Platelet counts were significantly lower in hypertensive compared to normotensive. This could be as result of endothelial dysfunction that leads to platelet activation and clot formation. This is in agreement with previous work where during hypertension, there is endothelial dysfunction which leads to platelet activation and clot formation causing platelets to be consumed, thereby reducing the platelet count [<xref ref-type="bibr" rid="scirp.125452-ref20">20</xref>] .</p><p>Furthermore, this study showed that Mean Cell Volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration (Red cells indices) were significantly higher in hypertensive compared to normotensive subjects. The trend is comparable to the findings of Bamlaku et al. (2017) on a comparative cross- sectional study of some haematological parameters of hypertensive and normotensive individuals at the university of Gondar hospital, Northwest Ethiopia [<xref ref-type="bibr" rid="scirp.125452-ref21">21</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>Our findings show that hypertension may be associated with haematological derangement if not properly managed. Therefore, haematological parameters can be used to monitor the prognosis of the disease and manage hypertensive related complications. It is important to assess haematological parameters for hypertensive individuals which may help to prevent complications associated with haematological disorders. Anaemia is associated with higher cardiovascular risk, higher blood pressure values, and lower dipping status in hypertensive patients, and haemoglobin concentration should be monitored in hypertensive patients</p></sec><sec id="s6"><title>Recommendations</title><p>Based on these findings, it is recommended that a drastic awareness/education on the dangers and need to check blood pressure more frequently be made. Also, red cell indices such as PCV, HB, MCV, MCH and MCHC are made routine tests during evaluation of hypertensive subjects.</p></sec><sec id="s7"><title>Contribution to Knowledge</title><p>This research contributes to knowledge by exposing the frontiers of researchers to the knowledge that some haematological parameters (red cell indices) such as MCV, MCH and MCHC play significant roles in hypertension management.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>Authors have declared that no competing interests exist.</p></sec><sec id="s9"><title>Cite this paper</title><p>Onyema, E.B., Kelechi, A., Anslem, A. and Chinedu, O.E. (2023) Some Haematological Parameters in Primary Hypertensive Subjects Attending a Tertiary Hospital in Nigeria. Open Journal of Blood Diseases, 13, 69-77. https://doi.org/10.4236/ojbd.2023.132009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.125452-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Carretero, O.A. and Oparil, S. (2000) Essential Hypertension. Part I: Definition and Etiology. Circulation, 101, 329-335. https://doi.org/10.1161/01.CIR.101.3.329</mixed-citation></ref><ref id="scirp.125452-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K. and He, J. (2005) Global Burden of Hypertension: Analysis of Worldwide Data. The Lancet, 365, 217-223. https://doi.org/10.1016/S0140-6736(05)17741-1</mixed-citation></ref><ref id="scirp.125452-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Damilola, O. (2018) Hypertension Affects about One Third of Nigerians. To What Social Stratum Patients belong Makes a Difference in How They Handle Their Condition. Last Contributed to D+C/E+Z in Spring of 2018 as Senior Correspondent at THISDAY Newspaper in Abuja, Nigeria.</mixed-citation></ref><ref id="scirp.125452-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Boos, C.J. and Lip, G.Y. (2005) Elevated High-Sensitive C-Reactive Protein, Large Arterial Stiffness and Atherosclerosis: A Relationship between Inflammation and Hypertension? Journal of Human Hypertension, 19, 511-513. https://doi.org/10.1038/sj.jhh.1001858</mixed-citation></ref><ref id="scirp.125452-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Shankar, A., Barbara, E.K. and Klein, R. (2004) Relationship between White Blood Cell Count and Incident Hypertension. American Journal of Hypertension, 17, 233-239. https://doi.org/10.1016/j.amjhyper.2003.11.005</mixed-citation></ref><ref id="scirp.125452-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Bao, W., Dalferes, E.R., Srinivasan, S.R., Webber, L.S. and Berenson, G.S. (1993) Normative Distribution of Complete Blood Count from Early Childhood through Adolescence: The Bogalusa Heart Study. Preventive Medicine, 22, 825-837. https://doi.org/10.1006/pmed.1993.1075</mixed-citation></ref><ref id="scirp.125452-ref7"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rampling</surname><given-names> M.W. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Haemorheological Disturbances in Hypertension: The Influence of Diabetes and Smoking</article-title><source> Clinical Hemorheology and Microcirculation</source><volume> 21</volume>,<fpage> 183</fpage>-<lpage>187</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.125452-ref8"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sandhagen</surname><given-names> B. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Red Cell Fluidity in Hypertension</article-title><source> Clinical Hemorheology Microcirculation</source><volume> 21</volume>,<fpage> 179</fpage>-<lpage>181</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.125452-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Kusunoki, T., Katoh, T., Ohtsuka, N., Takayama, S. and Abe, M. (2012) A Slightly Low Hemoglobin Level Is Beneficially Associated with Arterial Stiffness in Japanese Community-Dwelling Women. Clinical and Experimental Hypertension, 34, 92-98. https://doi.org/10.3109/10641963.2011.618202</mixed-citation></ref><ref id="scirp.125452-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kanbay, M., Akcay, A., Delibasi, T., Uz, B., Kaya, A. and Koca, C. (2007) Comparison of Effects of Darbepoetin Alfa and Epoetin Alfa on Serum Endothelin Level and Blood Pressure. Advances in Therapy, 24, 346-352. https://doi.org/10.1007/BF02849903</mixed-citation></ref><ref id="scirp.125452-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Berridge, M.J. (2014) Module 11: Cell Stress, Inflammatory Responses and Cell Death. Cell Signaling Biology, 14, 261-289. https://doi.org/10.1042/csb0001011</mixed-citation></ref><ref id="scirp.125452-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Brown, D., Giles, W.H. and Croft, J.B. (2001) White Blood Cell Count: An Independent Predictor of Coronary Heart Disease Mortality among a National Cohort. Journal of Clinical Epidemiology, 54, 316-322. https://doi.org/10.1016/S0895-4356(00)00296-1</mixed-citation></ref><ref id="scirp.125452-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Kim, D.J., Noh, J.H., Lee, B.W., Choi, Y.H., Chung, J.H. and Min, Y.K. (2008) The Associations of Total and Differential White Blood Cell Counts with Obesity, Hypertension, Dyslipidemia and Glucose Intolerance in a Korean Population. Journal of Korean Medical Science, 23, 193-198. https://doi.org/10.3346/jkms.2008.23.2.193</mixed-citation></ref><ref id="scirp.125452-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Babu, K.R., Kumar, N.L.G., Solepure, A.B. and Shaikh, R. (2015) Comparison of Haematological Parameters in Primary Hypertensives and Normotensives of Sangareddy. International Journal of Biomedical Research, 6, 309-315. https://doi.org/10.7439/ijbr.v6i5.1994</mixed-citation></ref><ref id="scirp.125452-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Jadeja, U., Jadeja, J. and Naik, S. (2011) Comparative Study of Haemoglobin Concentration in Hypertensive and Normotensive Subjects. Indian Journal of Applied Basic Medical Sciences, 13, 7.</mixed-citation></ref><ref id="scirp.125452-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Reis, R.S., Bensenor, I.J. and Lotufo, P.A. (1999) Laboratory Assessment of the Hypertensive Individual. Value of the Main Guidelines for High Blood Pressure. Arquivos Brasileiros de Cardiologia, 73, 201-210. https://doi.org/10.1590/S0066-782X1999000800008</mixed-citation></ref><ref id="scirp.125452-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Smebye, M.L., Iversen, E.K., H&amp;#248;ieggen, A., Flaa, A., Os, I. and Kjeldsen, S.E. (2007) Effect of Hemoglobin Levels on Cardiovascular Outcomes in Patients with Isolated Systolic Hypertension and Left Ventricular Hypertrophy (from the LIFE Study). American Journal of Cardiology, 100, 855-859. https://doi.org/10.1016/j.amjcard.2007.03.109</mixed-citation></ref><ref id="scirp.125452-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Karabulut, A. and Karadag, A. (2015) Clinical Implication of Hematological Indices in the Essential Hypertension. World Journal of Hypertension, 5, 93-97. https://doi.org/10.5494/wjh.v5.i2.93</mixed-citation></ref><ref id="scirp.125452-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Schillaci, G., Pirro, M., Pucci, G., Ronti, T., Vaudo, G., Mannarino, M.R., Porcellati, C. and Mannarino, E. (2018) Prognostic Value of Elevated White Blood Cell Count in Hypertension. American Journal of Hypertension, 20, 364-369. https://doi.org/10.1016/j.amjhyper.2006.10.007</mixed-citation></ref><ref id="scirp.125452-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Inanc, T., Kaya, M.G., Yarlioglues, M., Ardic, I., Ozdogru, I. and Dogan, A. (2010) The Mean Platelet Volume in Patients with Non-Dipper Hypertension Compared to Dippers and Normotensives. Blood Pressure, 19, 81-85. https://doi.org/10.3109/08037050903516284</mixed-citation></ref><ref id="scirp.125452-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Bamlaku, E., Nigist, A., Betelihem, T., Fikir, A. and Mulugeta, M. (2017) A Comparative Cross-Sectional Study of Some Hematological Parameters of Hypertensive and Normotensive Individuals at the University of Gondar Hospital, Northwest Ethiopia. Boston Medical Center Hematology, 17, 93-99. https://doi.org/10.1186/s12878-017-0093-9</mixed-citation></ref></ref-list></back></article>